510(k) Report

510(k) · Cleared

Cleared

Touch Tear Ige Microassay Kit

K991316510(k) TraditionalCleared Aug 9, 1999112-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Touch Scientific, Inc. · DGC Ige, Antigen, Antiserum, Control

Cleared on Aug 9, 1999 after a 112-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 2 later devices descend from it.

Decided
Aug 9, 1999
Review
112 days
Class
Class II
Product code
DGC
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2009: 1 descendant cleared2013: 1 descendant cleared1995200020052010201520202025
  1. This deviceK991316 Touch Tear Ige Microassay KitTouch Scientific, Inc. · 1999
  2. Descendant · cites it directly · 1 of its ownK083184 Tearlab Osmolarity SystemOcusense, Inc. · 2009
  3. Descendant · 2 generations on · 0 of its ownK132066 Inflamma DryRapid Pathogen Screening, Inc. · 2013 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K083184Tearlab Osmolarity SystemOcusense, Inc. · 2009 · cites it directly1descendant
  • K132066Inflamma DryRapid Pathogen Screening, Inc. · 2013 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K991316Touch Tear Ige Microassay KitTouch Scientific, Inc.1999—
+1K083184Tearlab Osmolarity SystemOcusense, Inc.2009—
+2K132066Inflamma DryRapid Pathogen Screening, Inc.20133

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201310
FIG. 1 — Lineage of K991316, 1999–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DGC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DGC device

  1. #1 K231151 Kenota 1 Total IgE; Kenota 1 (instrument)score 8.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K083184Tearlab Osmolarity SystemOcusense, Inc.20091

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K083184 (Ocusense, Inc., 2009) has gone furthest, with 1 descendant of its own.

How does its category compare?

All DGC devices

DGC Ige, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DGC

1in 2024

2007: 12014: 12016: 12020: 12022: 12023: 12024: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DGC

Too few DGC 510(k)s in any year since 2007 to give a median.

Recalls per year · DGC

1in 2016

2009: 12016: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DGC

2in 2021

2008: 22009: 52010: 122011: 132013: 12014: 12015: 22016: 22021: 2
2007high 13 (2011) · low 0 (2007)2025

MAUDE reports naming product code DGC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20090—15
20100—012
20110—013
20120—00
20130—01
20141—01
20150—02
20161—12
20170—00
20180—00
20190—00
20201—00
20210—02
20221—00
20231—00
20241—00
20250—00
20260—0—

What is it indicated for?

The TOUCH TEAR IGE MICROASSAY KIT is an in vitro diagnostic device which is used for the quantitative determination of Immunoglobulin E (IgE) concentration in human tears. This can be used as an aid in the diagnosis of ocular Type 1 allergic conjunctivitis or the allergic component of ocular inflammatory responses.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991316: Touch Tear Ige Microassay Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991316

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026